Journal profile · Toxicology

Mutagenesis

ISSN 0267-8357 · eISSN 1464-3804 · Oxford University Press · ENGLAND · Bimonthly · Founded 1986

Mutagenesis: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.03; hybrid open access; APC about USD 4,170; median 131 days to acceptance (60 articles, last 24 months); community-reported acceptance: moderate; 27 articles in 2025; indexed in SCIE and Scopus.

Impact factor3.03Latest value listed by LetPub
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review time131 daysMedian, submission to acceptance · 60 articles, last 24 months · PubMed
APCUSD 4,170Hybrid journal: charged only for open-access articles
AcceptanceModerateCommunity average
Articles per year272025 · OpenAlex count

Scope

Aims, scope and focus

Mutagenesis is published by Oxford University Press and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Carcinogens and Genotoxicity Assessment, DNA Repair Mechanisms and DNA and Nucleic Acid Chemistry, together about 56.2% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)

Mutagenesis is an international multi-disciplinary journal designed to bring together research aimed at the identification, characterization, and elucidation of the mechanisms of action of physical, chemical and biological agents capable of producing genetic change in living organisms (encompassing human, terrestrial and ecological species). The journals scope includes the study of the consequences of such changes on public and environmental health, also extending to human risk assessment and applied mutagenesis. The development and application of novel technologies for assessing hazard and/or risks following exposure to exogenous agents are also of interest, including (but not limited to): High-throughput/high-content approaches, Quantitative modelling approaches, Artificial intelligence, Error-corrected next-generation sequencing, Population based biomonitoring, 3Rs technologies aimed at replacing in vivo testing, Omic-technologies (e.g., transcriptomics, proteomics, metabolomics etc). Furthermore, Mutagenesis welcomes high-quality, robustly conducted studies that report negative results. A variety of different types of manuscripts are published in Mutagenesis: Original articles Reporting the results of fundamental and molecular studies upon the mechanisms of induction of point, chromosomal, genomic mutations and epigenetic change, and their roles in inherited and somatic disorders. In addition to investigating DNA damage and genetic instability, the journal is interested in studies on DNA repair, genomics, epigenomics, cancer research, molecular and environmental toxicology. Papers on guidelines for mutagenicity testing of environmental agents which describe and discuss new and emerging techniques, quality control and standards necessary for adequate testing of environmental agents. Cell lines, strains, DNA probes etc. The submission to and acceptance of a manuscript for publication in Mutagenesis implies that the authors will provide samples of such materials as cell lines, strains, mutants and DNA probes described in their publication to other investigators for research purposes. Ethics In reports of investigations in humans or animals, authors must explicitly indicate (in the appropriate section of the Methods) their adherence to ethical standards and note the approval of an ethics committee when this is relevant. Animal husbandry. Papers that report experiments involving live animals must include a statement that the animals were treated and housed

From the journal's Aims & Scope

Research area (LetPub): Toxicology

Editor-in-chief Gareth J. S.Publisher website

Editorial board by country: 1 in mainland China (about 3%); most named United Kingdom 9, United States 5, Japan 5, Italy 2, Norway 2 (35 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Carcinogens and Genotoxicity AssessmentBiochemistry, Genetics and Molecular Biology30.9%
  2. DNA Repair MechanismsBiochemistry, Genetics and Molecular Biology18.8%
  3. DNA and Nucleic Acid ChemistryBiochemistry, Genetics and Molecular Biology6.5%
  4. Effects and risks of endocrine disrupting chemicalsEnvironmental Science5.4%
  5. CRISPR and Genetic EngineeringBiochemistry, Genetics and Molecular Biology3.1%
  6. Genetically Modified Organisms ResearchAgricultural and Biological Sciences2.8%
  7. Molecular Biology Techniques and ApplicationsBiochemistry, Genetics and Molecular Biology2.7%
  8. Plant Genetic and Mutation StudiesAgricultural and Biological Sciences2.6%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorGenetics & HeredityZone 4
MinorToxicologyZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorGenetics & HeredityZone 3
MinorToxicologyZone 3

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorGenetics & HeredityZone 4
MinorToxicologyZone 4

Top journal: noReview journal: no

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

MEDLINEPubMedEmbaseCASCAB AbstractsCurrent ContentsPublisher website

Other: ProQuest

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
3.03LetPub ·
Impact factor (publisher) 2025
3.2Publisher website ·
5-year impact factor (publisher) 2025
7.7Publisher website ·
CiteScore 2026-06
7.7LetPub ·
CiteScore (publisher) 2025
7.7Publisher website ·
SJR 2026-06
1.15LetPub ·
SNIP 2026-06
1.34LetPub ·
h-index
82LetPub ·
h-index
123OpenAlex ·
i10-index
2,083OpenAlex ·
2-year mean citedness
2.7OpenAlex ·
Self-citation rate
9.7%LetPub ·
Share of gold OA articles
43.21%LetPub ·

Volume

Articles per year
23LetPub ·

Articles by year OpenAlex count · 3,135 in total · the current year is incomplete

YearArticlesOpen accessCitations
202633128
2025271678
20242922154
20233728350
20222615740
20214122450

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

131 daysMedian, submission to acceptance · P25–P75 104 days – 175 days

Acceptance to online
median 8 days (15 articles)
Submission to online
median 161 days
Sample
60 articles with submission and acceptance dates (81 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
6–12 weeksLetPub ·
Average acceptance (community reports)
ModerateLetPub ·

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Hybrid open accessLetPub

A subscription journal in which authors can pay to publish their article open access.

SourceAPCFee waiverLicenseObserved
OpenAlexGBP 3,162——

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
Oxford University Press
Country or region
ENGLAND
Language
English
Frequency
Bimonthly
Founded
1986
ISSN
0267-8357
Electronic ISSN
1464-3804
Society / sponsor
UKEMS
Latest issue on the website
Volume 41, Issue 5 (September 2026)
Official links

FAQ

Frequently asked questions about Mutagenesis

What CAS zone is Mutagenesis in?

In the 2025 upgraded edition of the CAS Journal Ranking, Mutagenesis is in Zone 4 of Medicine, and in Zone 4 of the minor category Genetics & Heredity / Toxicology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Mutagenesis?

The latest impact factor listed by LetPub is 3.03; CiteScore 7.7, h-index 123.

How long does peer review take at Mutagenesis?

Based on the dates recorded on 60 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 131 days (interquartile range 104–175 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Moderate”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Where are the editorial board members of Mutagenesis based?

Of the 35 board members whose country the journal's board page names, 1 (about 3%) are in mainland China; the countries named most often are United Kingdom (9), United States (5) and Japan (5). Counted from the institutions listed on the board page; for reference only.

Which databases index Mutagenesis?

According to LetPub and DOAJ records, Mutagenesis is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.

Is Mutagenesis open access, and what is the APC?

Mutagenesis is a hybrid journal. For open-access publication: APC about USD 4,170.

Sources and updates

The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .